Top brokerage calls for May 31: CLSA downgrades Glenmark Pharma, Nomura upgrades Alkem Labs
Updated : May 31, 2019 08:17 AM IST
CLSA On Glenmark Pharma- Downgrade to sell from buy, target cut to Rs 500 from Rs 740 per share
Nomura on Alkem Labs- Upgrade to buy from neutral, target raised to Rs 2,230 from Rs 1,965 per share
Macquarie on ONGC- Outperform call, target at Rs 210 per share
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morning
YOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more